NAMS
NASDAQ · Biotechnology
Newamsterdam Pharma Co Nv
$23.32
+0.74 (+3.28%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
-13.79%
YTD
-33.75%
Open$22.91
Previous Close$22.58
Day High$23.73
Day Low$22.13
52W High$42.21
52W Low$21.02
Volume—
Avg Volume1.81M
Market Cap2.67B
P/E Ratio—
EPS$-2.15
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$34.11
Below
SMA 200
$28.53
Below
RSI (14)
66.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
23 analysts
Price Target
+56.0% upside
Current
$23.32
$23.32
Target
$36.39
$36.39
$23.00
$36.39 avg
$47.36
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 22.53M | 36.72M | 2.72B |
| Net Income | -204,043,070 | -299,378,485 | 249.35M |
| Profit Margin | -905.7% | -860.5% | 9.2% |
| EBITDA | -225,714,718 | -349,574,473 | 355.91M |
| Free Cash Flow | — | — | 147.67M |
| Rev Growth | -38.7% | -38.7% | +24.9% |
| Debt/Equity | — | — | 0.72 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |